pSFV_Nb139-NLS-VP64 (3'UTR)_RLEloop
(Plasmid
#240256)
-
PurposeAttenuated PROTEUS vector with Nb139-VP64 transgene. Package VLVs with an envelope-expressing vector such as pCMV-VSV-G, or a transgene-responsive VSV-G expression vector.
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 240256 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $89 | |
Backbone
-
Vector backbonepcDNA3.1(+)
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namenanobody Nb139
-
Alt nameNb139-VP64
-
SpeciesLama glama, Herpes simplex virus type-1
-
MutationVP64 = 4*VP16[aa437-447]
- Promoter SFV subgenomic promoter
-
Tag
/ Fusion Protein
- NLS-VP64 (C terminal on insert)
Cloning Information
- Cloning method Other
Resource Information
-
A portion of this plasmid was derived from a plasmid made byIDT
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Nanobody sequence was synthesized by IDT, based on protein sequence from Bethuyne et al., 2014 (https://doi.org/10.1093/nar/gku962)
VP64 was synthesized by IDT.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pSFV_Nb139-NLS-VP64 (3'UTR)_RLEloop was a gift from Gregory Neely (Addgene plasmid # 240256 ; http://n2t.net/addgene:240256 ; RRID:Addgene_240256) -
For your References section:
A chimeric viral platform for directed evolution in mammalian cells. Cole AJ, Denes CE, Moreno CL, Hunault L, Dobson T, Hesselson D, Neely GG. Nat Commun. 2025 May 7;16(1):4250. doi: 10.1038/s41467-025-59438-2. 10.1038/s41467-025-59438-2 PubMed 40335481